Biotech · Private company
Tolmar Inc.
Track this companyFree. Adds Tolmar Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials53 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Anastrozole TabletsPhase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Exemestane TabletsPhase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Letrozole TabletsPhase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Leuprolide Acetate 45 mgPhase 3 · Precocious Puberty, CentralClinicalTrials.gov · fetched Nov 12, 2026
- TamoxifenPhase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- TOL2506Phase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Jatenzo Oral ProductHypogonadismClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 MonthsPHASE4 · COMPLETED · started Jul 2, 2024ClinicalTrials.gov NCT06385509 · fetched Nov 12, 2026
- Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA StudyPHASE3 · ENROLLING_BY_INVITATION · started Dec 28, 2022ClinicalTrials.gov NCT05645536 · fetched Nov 12, 2026
- Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Jul 1, 2021ClinicalTrials.gov NCT04906395 · fetched Nov 12, 2026
- A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer PatientsNA · ACTIVE_NOT_RECRUITING · started Oct 21, 2015ClinicalTrials.gov NCT03127631 · fetched Nov 12, 2026
- Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious PubertyPHASE3 · COMPLETED · started Aug 31, 2015ClinicalTrials.gov NCT02452931 · fetched Nov 12, 2026